Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ASKH $4.59 130 mil mkt cap still doable
In ASKH terms Mr Adder sir?
GTII 64 mil float $5.31 otc is not dead lol
QMEI annual numbers out, Potse
This is some serious stuff on these numbers. My goodness, on a 300k float. What they could do with that if they wanted to. I just wish they would start to communicate more with the markets.
https://www.otcmarkets.com/otcapi/company/financial-report/348038/content
8k just filed
https://www.otcmarkets.com/filing/html?id=16106429&guid=KOX-knJPBAnKJth
52 week range is .03-$9.70
WINR .03----------->.22 on PR
TPIA - merger priced $1.56+
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ
https://finance.yahoo.com/news/ehave-announces-mycotopia-therapies-reaches-130000386.html
Float only 1m shares
Didn’t figure it would happen but I was down there just in case
Ha ha, I wanted a million down around 003 lol
No worries my good man, this can see .50 in a heartbeat again
60k x .50 =???????????????????????
I’ve been stink bidding around 003-004 for the past week, I saw the update so I moved a 300k bid to 01 only got like 60 K filled
Been sitting on 750k @ .035ish and looked for another 250k @.01 but it got away fast.
No fear Mr Adder sir, we got the King and not a pauper
$4.59 or ?????????????????????????????????????? ASKH the Coop
Got a few 01’s but not enough
CLHI Synergy update out, still down 50% on this buttttttttttttttttttttttt, impossible is nothing in the markets folks
YBGJ(.088)...$2.3+M of shares moved.......
On Friday, an entity controlled by the CFO sold 4,278,000 shares at 50 cents ($2,364,000). This was part of the proposed insider sales disclosed in the S-1 filing that finally was declared effective by the SEC on July 29. Next large insider sale might be a 5.7M block at 50 cents, from an entity controlled by a YBGJ director. The only other proposed insider sale is a 1.7M block from Cheung Ho Shun (but there is a possibility that he has changed his mind about selling, since he indirectly purchased an additional 1.6M shares at 50 cents about 3 weeks ago).
In my opinion movement of these large amounts of shares at the fixed 50-cent price is encouraging, especially in this difficult market environment. After these insider sales, I am semi-expecting to see an additional infusion of capital into the company at 50 cents at some point, to go along with the $819K earlier this month.
HLTT(.45)...complex/interesting situation developing here.....
There are a lot of very complex elements going on with HLTT right now (they have a need for financing, revenue from their Amniobind product is expected to begin, other risks/catalysts you might expect from a biotech/medical company, etc). I have no idea how everything is going to play out (could be extremely good or extremely bad), but it is certainly an interesting situation.
One aspect of HLTT that is particularly interesting at the moment is its 5.5% ownership position in privately-held Varian Biopharma. Originally Varian was planning to go public via HLTT, but I think Varian/HLTT had difficulty attracting financing. Both parties mutually agreed to abandon the plan. So Varian then entered into a potential acquisition deal with SPK (a Nasdaq SPAC). As with most SPAC deals it is taking a considerable amount of time to get the deal closed.
Recently SPK mentioned in its filings that as part of closing the deal a simultaneous private placement was being worked on. I found that a bit interesting (and somewhat unusual) because the SPAC already had a fairly decent amount of cash (around $50M). SPK recently had its vote to extend the time for the SPAC to complete its acquisition and the 8-K disclosed a couple of items that caught my attention: 1) One day before the vote an institutional investor agreed to pay the first month's extension. I am not entirely sure but it is possible this investor may not have had any previous relationship with this SPAC. 2) More than 61% of the SPAC's shares were tendered for redemption. There are now only a little more than 2.5M shares outstanding in this SPAC.
That recent disclosure of work being done on a private placement and the institutional investor paying the first extension almost suggests to me that SPK probably was aware there would be a high number of redemptions but SPK/Varian might still be interested in trying to get a deal completed. If that is the case it will be interesting to see what kind of adjustments might be made to the original terms of the deal and what (if any) positive/negative impact it might have on HLTT. Under the original deal, HLTT was going to own a little more than 2.2% of the post-merger company.
Perhaps worth noting: Ever since HLTT issued 25-cent stock options to a debt holder on September 6 (the stock was trading around 20 cents at the time), and SPK had its extension vote on September 9, HLTT has quietly doubled in price. HLTT's ownership position in Varian Biopharma probably is not all that significant if you look at it from just a purely/overall fundamental perspective. But it probably does have some market awareness and psychological significance when you consider that one of the OTC investment themes that has garnered some increased interest recently has been with OTC stocks that have some connections to Nasdaq stocks. The HLTT/Varian/SPK connection is one that very few investors are probably aware of at the moment.
Coming at youuuuuuuuuuuuuuuuuuuuu,,,NEVER my good man.
Semper Fi
ASKH $4.59 or ?????????????????????????????????????????
That's why I was kidding you about not selling less than $1.59.
You came at me a little...
Who knows the potential here.
Have a great night!
$ASKH
You want me to sleep tonight or what lol
With all these revised PT, beginning to think $1.59 is on the low end!!!
Sheesh, 8,160,000 x $27.99=Hail to the KIng
Much obliged Mr Adder sir, wouldn't want to insult the lad
In ASKH terms $27.99
GSUN China 18 mil OS 6 mil float $45!
It was “beautiful” lol
Well, well, welcome you glorious or was that beautiful bastard
PNGAF
Products, great CEO, partnerships, website, ready to fly imo
Wow, ye Recluse likes $2.59 better than $1.59
That’s a big $2.59 on the ASKH scale
In ASKH denomination Mr Adder sir?????????????????????
GTVI .48 another low float rocket today
APSI hod .395
CLHI down the pisser.
VBIXD(.51)...Gix Media expects $80-90M 2022 revenue......
Added some more shares to my position both before and after the 1:28 reverse split. Risk/reward looks somewhat interesting down around this 50-80 cent price area. The incoming reverse merger target (Gix Media) did a little over $43M revenue in the first 6 months of this year, and the June 2022 (page 19) presentation below has the company providing guidance/expectation of $80-90M revenue for fiscal 2022.
I'm still not completely sure what the final post-RM share structure will look like. There are a few complicating factors (like whether some high-priced warrants get exercised, exactly how a loan to Gix's parent company will be repaid, etc.). But if my rough calculations/guess is reasonably close, I think the shares outstanding will probably be somewhere in the 12.5M to 18M range (my guess is that it will be roughly 15M).
https://mayafiles.tase.co.il/rpdf/1457001-1458000/P1457040-00.pdf
Canadian firms and residents only I heard - Questrade one of ‘em - I’m sure there’s some other countries involved but no US
Anyone figured out how to buy off the Expert Market yet?
LFEV(.413)...design/manufacture of AREB's e-bikes......
Still holding a position in the LFEV shell, waiting for the reverse merger with Life Electric to be officially completed, and still crossing my fingers there will be some type of momentum run. Share structure and valuation post-RM probably will be unattractive (around 457M outstanding), but the tradeable shares might still be reasonably low.
There has not been any official disclosure yet but it appears that one of the several additional acquisitions that LFEV has been working on is Sierra E-Bikes......
"If one cannot predict right, predict often."
Also when they see a chart turn they’ll try to stir up some selling and then come back a week later about how they bought x and sold at y. Conniving POS.
Followers
|
177
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
5845
|
Created
|
02/02/12
|
Type
|
Free
|
Moderator Involuntary-Recluse | |||
Assistants TURCH puffadder |
Identify and target the following opportunities:
Posts Today
|
1
|
Posts (Total)
|
5845
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |